CENTESSA PHARMACEUTICALS-ADR (CNTA) Institutional Ownership Changes & 13F Activity
CENTESSA PHARMACEUTICALS-ADR (CNTA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Pentwater Capital Management Lp, General Atlantic, L.P., Paradigm Biocapital Advisors Lp, Morgan Stanley, and Avoro Capital Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Torno Capital, Llc | Buy | +20,000 | — | 20,000 | $794.40K | Q1 2026 | Aug 17, 2026 |
| Mirae Asset Global Investments Co., Ltd. | Buy | +1,550 | +33.1% | 6,238 | $247.77K | Q1 2026 | Aug 12, 2026 |
| Wells Fargo & Company/Mn | Buy | +2,613 | +77.1% | 6,000 | $238.32K | Q1 2026 | Jul 08, 2026 |
| Bank Of America Corp | Buy | +982,862 | +103.5% | 1,932,406 | $76.76M | Q1 2026 | May 18, 2026 |
| Pentwater Capital Management Lp | Buy | +8,170,000 | — | 8,170,000 | $324.51M | Q1 2026 | May 15, 2026 |
| General Atlantic, L.P. | Sell | -4,762,885 | -77.9% | 1,354,830 | $53.81M | Q1 2026 | May 15, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +3,574,048 | — | 3,574,048 | $141.96M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +3,159,255 | +284.8% | 4,268,353 | $169.54M | Q1 2026 | May 15, 2026 |
| Avoro Capital Advisors Llc | Sell | -3,125,100 | -21.5% | 11,430,455 | $454.02M | Q1 2026 | May 15, 2026 |
| Ecor1 Capital, Llc | Buy | +2,885,000 | +92.6% | 6,000,000 | $238.32M | Q1 2026 | May 15, 2026 |
| Adage Capital Partners Gp, L.L.C. | Sell | -2,356,731 | -20.9% | 8,925,010 | $354.50M | Q1 2026 | May 15, 2026 |
| Perceptive Advisors Llc | Buy | +2,341,269 | +80.2% | 5,258,903 | $208.88M | Q1 2026 | May 15, 2026 |
| Fmr Llc | Sell | -2,109,892 | -23.5% | 6,852,047 | $272.16M | Q1 2026 | May 15, 2026 |
| Logos Global Management Lp | Buy | +1,925,000 | +962.5% | 2,125,000 | $84.41M | Q1 2026 | May 15, 2026 |
| Deep Track Capital, Lp | Buy | +1,158,041 | +57.9% | 3,158,041 | $125.44M | Q1 2026 | May 15, 2026 |
| Millennium Management Llc | Sell | -1,148,550 | -61.4% | 722,121 | $28.68M | Q1 2026 | May 15, 2026 |
| Jain Global Llc | Sell | -844,290 | -92.2% | 71,513 | $2.84M | Q1 2026 | May 15, 2026 |
| First Light Asset Management, Llc | Sell | -717,949 | -31.5% | 1,560,991 | $62.00M | Q1 2026 | May 15, 2026 |
| Eventide Asset Management, Llc | Buy | +668,142 | — | 668,142 | $26.54M | Q1 2026 | May 15, 2026 |
| Toronto Dominion Bank | Buy | +654,850 | — | 654,850 | $26.01M | Q1 2026 | May 15, 2026 |
| Tig Advisors, Llc | Buy | +648,326 | — | 648,326 | $25.75M | Q1 2026 | May 15, 2026 |
| Bain Capital Life Sciences Investors, Llc | Buy | +635,000 | — | 635,000 | $25.22M | Q1 2026 | May 15, 2026 |
| Janus Henderson Group Plc | Sell | -600,631 | -14.7% | 3,492,977 | $138.74M | Q1 2026 | May 15, 2026 |
| American Century Companies Inc | Sell | -442,331 | -39.2% | 687,427 | $27.30M | Q1 2026 | May 15, 2026 |
| Balyasny Asset Management L.P. | Buy | +384,013 | +81.9% | 852,828 | $33.87M | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +365,559 | +46.9% | 1,144,560 | $45.46M | Q1 2026 | May 15, 2026 |
| Alyeska Investment Group, L.P. | Buy | +320,430 | — | 320,430 | $12.73M | Q1 2026 | May 15, 2026 |
| Point72 Asset Management, L.P. | Buy | +307,355 | — | 307,355 | $12.21M | Q1 2026 | May 15, 2026 |
| Woodline Partners Lp | Buy | +280,854 | +48.6% | 859,105 | $34.12M | Q1 2026 | May 15, 2026 |
| Cormorant Asset Management, Lp | Sell | -275,000 | -20.8% | 1,050,000 | $41.71M | Q1 2026 | May 15, 2026 |
Frequently asked questions about CNTA activity
Which institutional owners are buying CNTA?
Institutional owners buying CNTA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CNTA activity?
"Buy" means an investor increased their reported position in CNTA compared to the prior reporting period. This reflects growing exposure to CENTESSA PHARMACEUTICALS-ADR (CNTA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CNTA increasing?
Institutional interest in CNTA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CNTA Institutional Insights
- CNTA Overview
- CNTA 13F Institutional Holders
- CNTA Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CNTA Insider Trading & SEC Form 4 Activity
- CNTA Articles
- Top Institutional Investor Stock Rankings